当前位置:首页>>博士后之家>>国外博士后招聘>>正文内容

美国密歇根大学安娜堡校区癌症生物学方向研究员

2018年03月29日
来源:知识人网
摘要:

Research Fellow in Cancer Biology

 
University of Michigan
Location: Ann Arbor, MI
Job Number: 7049846
Posting Date: Feb 5, 2018
Application Deadline: Open Until Filled
 
Job Description
Description
Postdoctoral position is available in Prof. Jolanta Grembecka laboratory, University of Michigan, Ann Arbor, to carry out an interdisciplinary project to study the effect of small molecules in in vitro and in vivo models of cancers and to pursue target validation studies using genetic approaches. We are seeking for a highly motivated postdoctoral fellow with extensive experience in cancer cell biology. The research will be focused on evaluation of the activity and the mechanism of action of novel small molecules blocking epigenetic proteins in cancer. This position requires the expertise in cell biology and molecular biology techniques, including PCR, qRT-PCR, Western Blotting, co-Immunoprecipitation, ChIP, ChIPSeq, flow cytometry, fluorescence microscopy, immunostaining. Prior work experience with animals such as transgenic mice and xenograft models of cancer would be desired. Successful candidate will be a part of an interdisciplinary team focused on development and pre-clinical evaluation of novel anti-cancer drug candidates.
 
Requirements
Applicant must have PhD in biology or related field. The candidates must be a first author on at least 2-3 publications. This position requires extensive experience in cell and molecular biology techniques. Furthermore, excellent oral and written communication skills in English are required as well as the ability to conduct independent scientific investigations.
 
How to apply
Please submit cover letter, CV, and contact information for 2-3 references combined into one PDF file by e-mail to: jolantag@umich.edu. 
 
Relevant publications:
1.Borkin, D. et al., Grembecka, J., Pharmacologic inhibition of the menin-MLL interaction blocks progression of MLL leukemia in vivo, Cancer Cell, 2015, 27 (4), 589-602.
2.He S, Grembecka J., Menin-MLL inhibitors block oncogenic transformation by MLL fusion proteins in a fusion partner independent manner. Leukemia. 2016 Feb;30(2):508-13.
 
Contact Information:
Jolanta Grembecka, Ph.D., Associate Professor
jolantag@umich.edu
Department of Pathology
1150 W. Medical Center Drive MSRB1 Room 4510D
Ann Arbor,Michigan 
United States
 
Tel: 734-615-3860